Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer (TOP0703)

Clinical Trial ID NCT00545948

PubWeight™ 1.50^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00545948

Top papers